ストックスクリーナーアプリを入手
0.2227
8.20%
-0.0199
プレマーケット:
.22
-0.0027
-1.21%
前日終値:
$0.2426
開ける：
$0.2415
24時間の取引高:
4.97M
Relative Volume:
0.28
時価総額：
$7.51M
収益：
-
当期純損益:
$-18.35M
株価収益率:
-0.192
EPS:
-1.16
ネットキャッシュフロー:
$-19.20M
1週間 パフォーマンス:
+5.85%
1か月 パフォーマンス:
-1.24%
6か月 パフォーマンス:
-48.22%
1年 パフォーマンス:
-86.25%
1日の値動き範囲:
$0.22
$0.249
1週間の範囲:
$0.2006
$0.2603
52週間の値動き範囲:
$0.1651
$2.03
Theriva Biologics Inc Stock (TOVX) Company Profile
名前
Theriva Biologics Inc
セクター
電話
301 417 4364
住所
9605 Medical Center Drive, Suite 270, Rockville
TOVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.2227 | 8.19M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Theriva Biologics Inc (TOVX) 最新ニュース
Will Theriva Biologics Inc. stock benefit from green energy trends2026 world cup usa national team semifinals defensive leaders pressing system match prediction preview - ulpravda.ru
Why Theriva Biologics Inc. stock is favored by pension funds2026 world cup usa national team quarterfinals goalkeepers low block defense match prediction statistical analysis - ulpravda.ru
How Theriva Biologics Inc. stock benefits from strong dollar2026 world cup usa national team group stage playmakers possession football winner prediction insights - ulpravda.ru
Theriva Biologics Incto Schedule End-of-Ph - 富途牛牛
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design - Yahoo Finance
Theriva Biologics gains EMA backing for VCN-01 phase 3 - MSN
Theriva receives EMA guidance for pancreatic cancer drug trial design By Investing.com - Investing.com Nigeria
Why Is Theriva Biologics Stock Gaining Monday? - Benzinga
Theriva Biologics stock soars after EMA backs Phase 3 trial design - Investing.com Canada
Theriva Biologics (TOVX) Prepares for Phase 3 Trial with EMA Gui - GuruFocus
Theriva Biologics Announces EMA Advice on Phase 3 Trial for VCN-01 - TradingView — Track All Markets
Theriva Biologics (TOVX) outlines EMA CHMP advice on VCN-01 Phase 3 trial in metastatic pancreatic cancer - Stock Titan
EMA advice moves Theriva's VCN-01 toward Phase 3 pancreatic trial - Stock Titan
Guidance Update: What market sentiment indicators show for Theriva Biologics Inc. (SFY0) stock2025 Macro Impact & Growth Focused Entry Point Reports - moha.gov.vn
Theriva Biologics (NYSEAMERICAN:TOVX) Trading 5.2% Higher – Here’s Why - Defense World
What drives Theriva Biologics Inc stock priceDebt-to-Equity Ratio Analysis & Free Expert Stock Watchlists - earlytimes.in
Theriva Biologics (TOVX) asks holders to OK 16.18M warrant shares, $8.7M cash - Stock Titan
Have you been able to find a good deal on Theriva Biologics Inc’s shares? - uspostnews.com
Highs Report: Why institutional investors increase stakes in Theriva Biologics Inc. (SFY0) stock2025 Market Sentiment & Safe Swing Trade Setup Alerts - moha.gov.vn
Why Theriva Biologics Inc. stock appeals to dividend investorsJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - Улправда
Hedge Fund Moves: Is Theriva Biologics Inc. stock supported by strong fundamentals2025 Market Overview & Precise Entry and Exit Recommendations - Улправда
Is Theriva Biologics Inc. stock supported by strong fundamentals - Улправда
How risky is Theriva Biologics Inc. stock nowFed Meeting & Free Accurate Trade Setup Notifications - Улправда
Can Theriva Biologics Inc. stock deliver strong Q4 earningsJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - DonanımHaber
Is Theriva Biologics Inc. stock at risk of policy regulationJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - DonanımHaber
What analyst consensus implies for Theriva Biologics Inc. (SFY0) stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - Улправда
Can Theriva Biologics Inc. stock deliver sustainable ROEMarket Trend Report & Weekly Setup with ROI Potential - DonanımHaber
Is Theriva Biologics Inc. stock a fit for income portfoliosJuly 2025 Fed Impact & High Return Stock Watch Alerts - DonanımHaber
Can Theriva Biologics Inc. stock sustain free cash flow growthWeekly Trade Review & Community Verified Swing Trade Signals - Улправда
Will Theriva Biologics Inc. (SFY0) stock draw ESG focused funds2025 Sector Review & Free Expert Approved Momentum Trade Ideas - Улправда
Why analysts recommend Theriva Biologics Inc. stock2025 EndofYear Setup & Fast Gain Stock Trading Tips - Улправда
Theriva Biologics to reschedule special stockholder meeting after lack of quorum - Investing.com Nigeria
Theriva Biologics Reschedules Special Stockholder Meeting - TipRanks
Theriva Biologics reschedules special stockholder meeting - MSN
Theriva Biologics (NYSE American: TOVX) to hold new vote on warrant share issuance - Stock Titan
US Market Recap: How Theriva Biologics Inc SFY0 stock reacts to stronger dollarQuarterly Growth Report & Fast Moving Trade Plans - moha.gov.vn
Earnings Risk: How Theriva Biologics Inc SFY0 stock responds to job market shiftsCPI Data & AI Powered Market Trend Analysis - moha.gov.vn
Why Theriva Biologics Inc. stock is a strong buy call2025 Analyst Calls & AI Driven Stock Reports - Newser
Can Theriva Biologics Inc. (SFY0) stock test all time highs2025 Market Overview & Verified Swing Trading Watchlists - Newser
Why Theriva Biologics Inc. stock gets analyst attention2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How Theriva Biologics Inc. (SFY0) stock reacts to Fed tightening2025 Market Overview & Smart Investment Allocation Insights - Newser
Will Theriva Biologics Inc. stock outperform foreign stocksTake Profit & Daily Profit Focused Stock Screening - Newser
Will Theriva Biologics Inc. stock maintain strong growthQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Can Theriva Biologics Inc. stock reach $200 price targetJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Will Theriva Biologics Inc. stock beat value stocksMarket Movers & Growth Focused Stock Pick Reports - Newser
Theriva Biologics (NYSE: TOVX) files resale for 16,184,560 warrant shares - Stock Titan
Can Theriva Biologics Inc. stock deliver consistent EPS growthPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Will Theriva Biologics Inc. stock top growth indexesTrade Exit Summary & Safe Entry Zone Identification - Newser
Theriva Biologics Inc (TOVX) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):